Erectile dysfunction: a review and update.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2004 AND VI 39 AND IP 5
Results: 27
1
2
Selected websites.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 272
- Publication type:
- Article
3
Erectile dysfunction: A review and update.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 261
- By:
- Publication type:
- Article
4
Rasagiline.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 255
- By:
- Publication type:
- Article
5
Selected literature.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 272
- Publication type:
- Article
6
Agents for Parkinson's disease.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 272
- Publication type:
- Article
7
Rasagiline: an oral irreversible MAO-B inhibitor for the treatment of Parkinson's disease.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
8
Changes to incentive-based formularies should be made gradually.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 252
- By:
- Publication type:
- Article
9
Safety labeling updates & new warnings.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 250
- Publication type:
- Article
10
Valproate improves 1-year IGE remission rate by more than 50%.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 248
- Publication type:
- Article
11
ICS use elevates fracture risk in COPD patients.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 250
- Publication type:
- Article
12
Zyprexa IntraMuscular.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 240
- Publication type:
- Article
13
Long-term safety of alendronate established in 10-year study.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 249
- Publication type:
- Article
14
COX inhibitors counter the effects of ACE inhibitors, elevate BP.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 249
- Publication type:
- Article
15
Acarbose prevents MI in patients with type 2 diabetes.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 248
- Publication type:
- Article
16
Health plans focus on new strategies to educate consumers about formularies.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 246
- Publication type:
- Article
17
Combination atopic dermatitis therapy reduces adverse effects.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 245
- Publication type:
- Article
18
New class may help smokers quit, curb post-cessation weight gain.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 245
- Publication type:
- Article
19
Enoxaparin clinically equivalent to UFH in the treatment of high-risk ACS.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 242
- Publication type:
- Article
20
Perfusion scanning following AMI can identify low-risk group.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 242
- Publication type:
- Article
21
Ezetimibe added to statin results in greater achievement of LDL goals.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 242
- Publication type:
- Article
22
FDA actions in brief.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 240
- Publication type:
- Article
23
First-time generic approvals.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 239
- Publication type:
- Article
24
Cardizem LA.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 239
- Publication type:
- Article
25
Vioxx.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 235
- Publication type:
- Article
26
Ketek.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 235
- Publication type:
- Article
27
Pipeline preview.
- Published in:
- Formulary, 2004, v. 39, n. 5, p. 235
- Publication type:
- Article